Atlas Trials

Spironolactone Versus Indapamide in Obese and Hypertensive Patients

Clinical trial NCT03626506 · UNKNOWN

Trial details

NCT number
NCT03626506
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hypertension
Start date
2019-02-13
Primary completion
2020-08-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.